DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.
Frequently asked questions
What sector does Diagnos Inc (ADK) operate in?
Diagnos Inc belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Diagnos Inc (ADK) current stock price?
As of the latest data, Diagnos Inc stock price is CA$0.41, with a previous close of CA$0.39. Diagnos Inc gained CA$0.02 in the last trading session, representing a 5.19% increase.
What is Diagnos Inc (ADK) current market capitalization?
Diagnos Inc market cap is approximately 48.77 million.
What is Diagnos Inc (ADK) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.04.
Does Diagnos Inc (ADK) pay dividends?
No. Diagnos Inc does not pay a dividend.
When is Diagnos Inc (ADK) next earnings report?
Diagnos Inc is expected to release its next earnings report on June 30, 2026.
What is Diagnos Inc (ADK) beta (volatility) score?
Diagnos Inc has a beta of -0.152, indicating lower volatility than the overall market.
